This article was originally published in The Gray Sheet
"Medical Device Update '98" meeting is planned for June 24-25 in Washington, D.C. Among the topics to be addressed by FDAers are: accelerated approvals and reviews (Susan Alpert, director, ODE); quality system regulation (Kimberly Trautman, Good Manufacturing Practices/Quality Systems Expert, Office of Compliance); international harmonization (Larry Kessler, director, Office of Surveillance and Biometrics); postmarket requirements (Thomas Gross, director, Division of Postmarket Surveillance, OSB); and refurbishers (Casper Uldricks, special assistant to the director, OC). For more information call 1/800-956-6293...
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.